U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07048249) titled 'Single Arm Romiplostim to Prevent CIT' on June 24.
Brief Summary: The goal of this clinical trial is to to assess the efficacy of romiplostim as a supportive care measure in patients with a new diagnosis of Ewing sarcoma receiving interval-compressed chemotherapy. The main questions it aims to answer are:
1. To demonstrate the efficacy of romiplostim in patients with newly diagnosed Ewing sarcoma, measured specifically as the rate of chemotherapy-induced thrombocytopenia (CIT), defined as a failure to achieve platelet recovery.
2. To determine the safety of incorporation of romiplostim supportive care when given concurrently with E...